• Shylicine Granted Orphan Designation americanpharmaceuticalreview
    October 29, 2020
    Vanessa Research (VR) has been granted positive orphan drug opinion by the European Medicines Agency (EMA) for their drug Shylicine™ (patent pending).
PharmaSources Customer Service